Venrock Healthcare Capital Partners III is a Venture Capital Fund in New York, that has raised $400.00 mm from 66 investors, for a fund started in Apr 2018. Data from SEC filing on 19 Apr 2018.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$554.10 mm
Address
Venrock Healthcare Capital Partners III
530 FIFTH AVENUE, 22ND FLOOR
NEW YORK
NY 10036
530 FIFTH AVENUE, 22ND FLOOR
NEW YORK
NY 10036
Phone
212-444-4100
Ownership
Fund structure | AUM | Fund type |
---|---|---|
VR Adviser, LLC | $2.02 bn | |
Venrock Healthcare Capital Partners Eg, L.P. | $515.75 mm | Hedge Fund |
Venrock Healthcare Capital Partners II, L.P. | $149.29 mm | Private Equity Fund |
Venrock Healthcare Capital Partners III, L.P. | $554.10 mm | Private Equity Fund |
Venrock Healthcare Capital Partners, L.P. | $1.42 mm | Private Equity Fund |
Venrock Opportunities Fund, L.P. | $678.40 mm | Private Equity Fund |
VHCP Co-investment Holdings II, LLC | $65.10 mm | Private Equity Fund |
Venrock Associates VI, L.P. | ||
Venrock Associates VII, L.P. | ||
Venrock Partners VI, L.P. | ||
Venrock Partners VII, L.P. | ||
VHCP Co-investment Holdings III, LLC | $55.43 mm | Private Equity Fund |
Venrock Associates VIII, L.P. | ||
Venrock Partners VIII, L.P. | ||
VHCP Co-investment Holdings, LLC | $359.87 k | Private Equity Fund |
Venrock Associates V, L.P. | ||
Venrock Partners V, L.P |
Latest filings (excl ownership)
Latest ownership filings
SC 13G
Aquestive Therapeutics, Inc.
1 Apr 24
SC 13G
Century Therapeutics, Inc.
4 Mar 24
SC 13G
enGene Holdings Inc.
26 Feb 24
4
Bong Y Koh
22 Feb 24
SC 13G/A
Applied Therapeutics Inc.
14 Feb 24
SC 13G/A
Avalo Therapeutics, Inc.
14 Feb 24
SC 13G/A
Mersana Therapeutics, Inc.
14 Feb 24
SC 13G/A
Milestone Pharmaceuticals Inc.
14 Feb 24
SC 13G/A
Cabaletta Bio, Inc.
14 Feb 24
SC 13G/A
Enliven Therapeutics, Inc.
14 Feb 24